Online Registry for Nationwide Database of Current Trend of Helicobacter pylori Eradication in Korea: Interim Analysis
Eradication of Helicobacter pylori using first-line therapy is becoming less effective. Subjects who had been treated for H. pylori infection were prospectively enrolled through an on-line database registry from October 2010 to December 2012. Demographic data, detection methods, treatment indication...
Saved in:
Published in | Journal of Korean medical science Vol. 31; no. 8; pp. 1246 - 1253 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Korea (South)
The Korean Academy of Medical Sciences
01.08.2016
대한의학회 |
Subjects | |
Online Access | Get full text |
ISSN | 1011-8934 1598-6357 |
DOI | 10.3346/jkms.2016.31.8.1246 |
Cover
Abstract | Eradication of Helicobacter pylori using first-line therapy is becoming less effective. Subjects who had been treated for H. pylori infection were prospectively enrolled through an on-line database registry from October 2010 to December 2012. Demographic data, detection methods, treatment indication, regimens, durations, compliance, adverse events, and eradication results for H. pylori infection were collected. Data of 3,700 patients from 34 hospitals were analyzed. The overall eradication rate of the first-line therapy was 73.0%. Eradication failure was significantly associated with old age, concomitant medication, and comorbidity. Regional differences in eradication rates were observed. The most common first-line therapy was proton pump inhibitor-based triple therapy (standard triple therapy, STT) for 7 days (86.8%). The eradication rates varied with regimens, being 73% in STT, 81.8% in bismuth-based quadruple therapy, 100% in sequential therapy, and 90.3% in concomitant therapy. The eradication rate in treatment-naïve patients was higher than that in patients previously treated for H. pylori infection (73.8% vs. 58.5%, P < 0.001). The overall eradication rate for second-line therapy was 84.3%. There was no statistical difference in eradication rates among various regimens. H. pylori eradication rate using STT is decreasing in Korea and has become sub-optimal, suggesting the need for alternative regimens to improve the efficacy of first-line therapy for H. pylori infection. |
---|---|
AbstractList | Eradication of Helicobacter pylori using first-line therapy is becoming less effective. Subjects who had been treated for H. pylori infection were prospectively enrolled through an on-line database registry from October 2010 to December 2012. Demographic data, detection methods, treatment indication, regimens, durations, compliance, adverse events, and eradication results for H. pylori infection were collected. Data of 3,700 patients from 34 hospitals were analyzed. The overall eradication rate of the first-line therapy was 73.0%. Eradication failure was significantly associated with old age, concomitant medication, and comorbidity. Regional differences in eradication rates were observed. The most common first-line therapy was proton pump inhibitor-based triple therapy (standard triple therapy, STT) for 7 days (86.8%). The eradication rates varied with regimens, being 73% in STT, 81.8% in bismuth-based quadruple therapy, 100% in sequential therapy, and 90.3% in concomitant therapy. The eradication rate in treatment-naïve patients was higher than that in patients previously treated for H. pylori infection (73.8% vs. 58.5%, P < 0.001). The overall eradication rate for second-line therapy was 84.3%. There was no statistical difference in eradication rates among various regimens. H. pylori eradication rate using STT is decreasing in Korea and has become sub-optimal, suggesting the need for alternative regimens to improve the efficacy of first-line therapy for H. pylori infection. Eradication of Helicobacter pylori using first-line therapy is becoming less effective. Subjects who had been treated for H. pylori infection were prospectively enrolled through an on-line database registry from October 2010 to December 2012. Demographic data, detection methods, treatment indication, regimens, durations, compliance, adverse events, and eradication results for H. pylori infection were collected. Data of 3,700 patients from 34 hospitals were analyzed. The overall eradication rate of the first-line therapy was 73.0%. Eradication failure was significantly associated with old age, concomitant medication, and comorbidity. Regional differences in eradication rates were observed. The most common first-line therapy was proton pump inhibitor-based triple therapy (standard triple therapy, STT) for 7 days (86.8%). The eradication rates varied with regimens, being 73% in STT, 81.8% in bismuth-based quadruple therapy, 100% in sequential therapy, and 90.3% in concomitant therapy. The eradication rate in treatmentnaïve patients was higher than that in patients previously treated for H. pylori infection (73.8% vs. 58.5%, P < 0.001). The overall eradication rate for second-line therapy was 84.3%. There was no statistical difference in eradication rates among various regimens. H. pylori eradication rate using STT is decreasing in Korea and has become sub-optimal, suggesting the need for alternative regimens to improve the efficacy of first-line therapy for H. pylori infection. KCI Citation Count: 2 Eradication of Helicobacter pylori using first-line therapy is becoming less effective. Subjects who had been treated for H. pylori infection were prospectively enrolled through an on-line database registry from October 2010 to December 2012. Demographic data, detection methods, treatment indication, regimens, durations, compliance, adverse events, and eradication results for H. pylori infection were collected. Data of 3,700 patients from 34 hospitals were analyzed. The overall eradication rate of the first-line therapy was 73.0%. Eradication failure was significantly associated with old age, concomitant medication, and comorbidity. Regional differences in eradication rates were observed. The most common first-line therapy was proton pump inhibitor-based triple therapy (standard triple therapy, STT) for 7 days (86.8%). The eradication rates varied with regimens, being 73% in STT, 81.8% in bismuth-based quadruple therapy, 100% in sequential therapy, and 90.3% in concomitant therapy. The eradication rate in treatment-naïve patients was higher than that in patients previously treated for H. pylori infection (73.8% vs. 58.5%, P < 0.001). The overall eradication rate for second-line therapy was 84.3%. There was no statistical difference in eradication rates among various regimens. H. pylori eradication rate using STT is decreasing in Korea and has become sub-optimal, suggesting the need for alternative regimens to improve the efficacy of first-line therapy for H. pylori infection. |
Author | Kim, Byung-Wook Han, Sok Won Park, Byung-Joo Jeon, Seong Woo Shin, Woon Geon Kim, Tae Ho Park, Sue K. Kim, Hyun-Soo Kim, Ji Hyun Kim, Sang Gyun Shim, Ki-Nam Jung, Yun Jin Kim, Kyung Ho Lee, Jun Haeng Chung, Il-Kwun Song, Hyun Joo Lee, Joongyub Kim, Jae G. Kim, Beom Jin Kim, Gwang Ha Kim, Sun Moon Yang, Chang-Hun |
AuthorAffiliation | 13 Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea 1 Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea 9 Department of Internal Medicine, Daegu Fatima Hospital, Daegu, Korea 12 Department of Gastroenterolgy, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Korea 16 Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea 18 Department of Biomedical Science, Seoul National University Graduate School, Seoul, Korea 4 Department of Internal Medicine, Cheonan Hospital, Soon Chun Hyang University College of Medicine, Cheonan, Korea 11 Department of Internal Medicine, Pusan Paik Hospital, Inje University College of Medicine, Busan, Korea 17 Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea 3 Department of Internal Medicine, Jeju National University School o |
AuthorAffiliation_xml | – name: 3 Department of Internal Medicine, Jeju National University School of Medicine, Jeju, Korea – name: 2 Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea – name: 17 Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea – name: 1 Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea – name: 15 Department of Internal Medicine, Konyang University College of Medicine, Daejeon, Korea – name: 5 Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea – name: 18 Department of Biomedical Science, Seoul National University Graduate School, Seoul, Korea – name: 14 Department of Internal Medicine, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea – name: 10 Department of Internal Medicine, Dongguk University College of Medicine Gyeongju Hospital, Gyeongju, Korea – name: 6 Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Incheon, Korea – name: 7 Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, Korea – name: 19 Cancer Research Institute, Seoul National University, Seoul, Korea – name: 9 Department of Internal Medicine, Daegu Fatima Hospital, Daegu, Korea – name: 11 Department of Internal Medicine, Pusan Paik Hospital, Inje University College of Medicine, Busan, Korea – name: 4 Department of Internal Medicine, Cheonan Hospital, Soon Chun Hyang University College of Medicine, Cheonan, Korea – name: 16 Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea – name: 8 Department of Internal Medicine, Kyungpook National University Medical Center, Daegu, Korea – name: 12 Department of Gastroenterolgy, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Korea – name: 13 Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea |
Author_xml | – sequence: 1 givenname: Beom Jin orcidid: 0000-0002-0938-6697 surname: Kim fullname: Kim, Beom Jin organization: Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea – sequence: 2 givenname: Hyun-Soo orcidid: 0000-0003-4834-0496 surname: Kim fullname: Kim, Hyun-Soo organization: Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea – sequence: 3 givenname: Hyun Joo orcidid: 0000-0002-4107-9590 surname: Song fullname: Song, Hyun Joo organization: Department of Internal Medicine, Jeju National University School of Medicine, Jeju, Korea – sequence: 4 givenname: Il-Kwun orcidid: 0000-0001-6732-9714 surname: Chung fullname: Chung, Il-Kwun organization: Department of Internal Medicine, Cheonan Hospital, Soon Chun Hyang University College of Medicine, Cheonan, Korea – sequence: 5 givenname: Gwang Ha orcidid: 0000-0001-9721-5734 surname: Kim fullname: Kim, Gwang Ha organization: Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea – sequence: 6 givenname: Byung-Wook orcidid: 0000-0002-2290-4954 surname: Kim fullname: Kim, Byung-Wook organization: Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Incheon, Korea – sequence: 7 givenname: Ki-Nam orcidid: 0000-0003-4004-6292 surname: Shim fullname: Shim, Ki-Nam organization: Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, Korea – sequence: 8 givenname: Seong Woo orcidid: 0000-0002-9539-9389 surname: Jeon fullname: Jeon, Seong Woo organization: Department of Internal Medicine, Kyungpook National University Medical Center, Daegu, Korea – sequence: 9 givenname: Yun Jin orcidid: 0000-0002-3622-9216 surname: Jung fullname: Jung, Yun Jin organization: Department of Internal Medicine, Daegu Fatima Hospital, Daegu, Korea – sequence: 10 givenname: Chang-Hun orcidid: 0000-0003-4036-2981 surname: Yang fullname: Yang, Chang-Hun organization: Department of Internal Medicine, Dongguk University College of Medicine Gyeongju Hospital, Gyeongju, Korea – sequence: 11 givenname: Ji Hyun orcidid: 0000-0003-0861-2792 surname: Kim fullname: Kim, Ji Hyun organization: Department of Internal Medicine, Pusan Paik Hospital, Inje University College of Medicine, Busan, Korea – sequence: 12 givenname: Tae Ho orcidid: 0000-0003-2015-5176 surname: Kim fullname: Kim, Tae Ho organization: Department of Gastroenterolgy, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Korea – sequence: 13 givenname: Sang Gyun orcidid: 0000-0003-1799-9028 surname: Kim fullname: Kim, Sang Gyun organization: Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea – sequence: 14 givenname: Woon Geon orcidid: 0000-0002-9851-5576 surname: Shin fullname: Shin, Woon Geon organization: Department of Internal Medicine, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea – sequence: 15 givenname: Sun Moon orcidid: 0000-0002-0436-3381 surname: Kim fullname: Kim, Sun Moon organization: Department of Internal Medicine, Konyang University College of Medicine, Daejeon, Korea – sequence: 16 givenname: Sok Won orcidid: 0000-0003-2705-778X surname: Han fullname: Han, Sok Won organization: Department of Gastroenterolgy, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Korea – sequence: 17 givenname: Jun Haeng orcidid: 0000-0002-5272-1841 surname: Lee fullname: Lee, Jun Haeng organization: Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea – sequence: 18 givenname: Kyung Ho orcidid: 0000-0002-9607-6258 surname: Kim fullname: Kim, Kyung Ho organization: Department of Internal Medicine, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea – sequence: 19 givenname: Sue K. orcidid: 0000-0001-5002-9707 surname: Park fullname: Park, Sue K. organization: Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea., Department of Biomedical Science, Seoul National University Graduate School, Seoul, Korea., Cancer Research Institute, Seoul National University, Seoul, Korea – sequence: 20 givenname: Byung-Joo orcidid: 0000-0003-4630-4942 surname: Park fullname: Park, Byung-Joo organization: Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea – sequence: 21 givenname: Joongyub orcidid: 0000-0003-2784-3772 surname: Lee fullname: Lee, Joongyub organization: Department of Biomedical Science, Seoul National University Graduate School, Seoul, Korea – sequence: 22 givenname: Jae G. orcidid: 0000-0002-4841-9404 surname: Kim fullname: Kim, Jae G. organization: Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27478335$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002131406$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNp9kUtvEzEUhS1URB_wC5CQl2wy2OPnsECK0kIjKipV2Vt3PJ7iZmIHe1KUf48ngfJYsPG1rr9zz7XOOToJMTiEXlNSMcblu4f1Jlc1obJitNIVrbl8hs6oaPRMMqFOyp1QOtMN46foPOcHQmohavYCndaKK82YOEOPt2HwweE7d-_zmPa4jwl_gdHH8N13Dl_CCC1kh2OPF7uUXBjxqpzd1Lh2g7exBTu6hLf7ISaPrxJ03h4GYB_w55gcvMfLUBC_wfMAwz77_BI972HI7tXPeoFWH69Wi-vZze2n5WJ-M7NcsnHW895q1wLhHVWOAxMgCWmlVqKVXa8UtU3dSAsNBWotFZo5kJ3suFSdbtkFenscG1Jv1tabCP5Q76NZJzO_Wy2NULUmuqAfjuh2125cZ8tHEwxmW7aGtD8I_34J_msZ82h4I6gQ_LfXNsVvO5dHs_HZumGA4OIuGzq5KMHquqBv_vR6MvkVSwHYEbAp5pxc_4RQYqbwzRS-mcI3jBptpvCLqvlHZf14SKIs7If_an8AX6e4HA |
CitedBy_id | crossref_primary_10_3904_kjim_2020_701 crossref_primary_10_4103_sjg_SJG_456_18 crossref_primary_10_3904_kjim_2019_139 crossref_primary_10_1111_hel_12646 crossref_primary_10_5009_gnl220429 crossref_primary_10_5056_jnm19209 crossref_primary_10_4166_kjg_2019_73_2_99 crossref_primary_10_7704_kjhugr_2017_17_1_11 crossref_primary_10_7704_kjhugr_2022_0026 crossref_primary_10_1111_hel_12780 crossref_primary_10_7704_kjhugr_2019_19_2_120 crossref_primary_10_5009_gnl17177 crossref_primary_10_1097_MD_0000000000013245 crossref_primary_10_1111_jgh_14625 crossref_primary_10_4166_kjg_2017_70_5_232 crossref_primary_10_5009_gnl19136 crossref_primary_10_7704_kjhugr_2019_19_2_106 crossref_primary_10_3748_wjg_v30_i2_184 crossref_primary_10_3390_antibiotics9100646 crossref_primary_10_4166_kjg_2023_039 crossref_primary_10_1080_19490976_2020_1754118 crossref_primary_10_7704_kjhugr_2020_0045 crossref_primary_10_4166_kjg_2018_72_5_237 crossref_primary_10_1186_s13063_017_2281_0 crossref_primary_10_1111_hel_12654 crossref_primary_10_3904_kjm_2021_96_2_116 crossref_primary_10_5009_gnl220256 crossref_primary_10_5009_gnl20225 crossref_primary_10_1186_s13099_020_00378_1 crossref_primary_10_5009_gnl20288 crossref_primary_10_3904_kjm_2021_96_3_160 crossref_primary_10_1007_s10620_021_06938_y |
Cites_doi | 10.1038/ncpgasthep1138 10.1111/j.1365-2036.2006.02994.x 10.4291/wjgp.v5.i4.392 10.4166/kjg.2011.58.2.67 10.1155/2012/757926 10.1111/j.1440-1746.2008.05314.x 10.1111/j.1572-0241.2007.01393.x 10.1007/s10620-014-3093-7 10.1111/j.1523-5378.2011.00856.x 10.1007/BF01213292 10.3109/00365529409094890 10.1056/NEJMcp1001110 10.1136/gutjnl-2012-302084 10.1097/00004836-200609000-00004 10.1093/jac/47.4.459 10.3346/jkms.2014.29.5.704 10.1016/j.annepidem.2004.11.001 10.4166/kjg.2009.54.5.269 10.4166/kjg.2011.57.4.221 10.1111/j.1365-2036.2011.04887.x 10.1186/1471-230X-13-104 10.1111/jgh.12397 10.1097/MCG.0b013e3181d04592 10.1046/j.1365-2036.1997.00210.x 10.1128/AAC.48.12.4843-4847.2004 10.3748/wjg.v21.i1.351 10.1111/hel.12018 10.4166/kjg.2010.55.6.368 10.1159/000357861 10.1056/NEJMra020542 |
ContentType | Journal Article |
Copyright | 2016 The Korean Academy of Medical Sciences. 2016 |
Copyright_xml | – notice: 2016 The Korean Academy of Medical Sciences. 2016 |
CorporateAuthor | Korean College of Helicobacter and Upper Gastrointestinal Research |
CorporateAuthor_xml | – name: Korean College of Helicobacter and Upper Gastrointestinal Research |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM ACYCR |
DOI | 10.3346/jkms.2016.31.8.1246 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Korean Citation Index |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1598-6357 |
EndPage | 1253 |
ExternalDocumentID | oai_kci_go_kr_ARTI_572808 PMC4951554 27478335 10_3346_jkms_2016_31_8_1246 |
Genre | Multicenter Study Journal Article Observational Study |
GrantInformation_xml | – fundername: ; |
GroupedDBID | --- 29K 2WC 3O- 5-W 53G 5GY 8JR 8XY 9ZL AAYXX ADBBV ADRAZ AENEX ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CITATION CS3 D-I DIK DU5 E3Z EBS EF. EJD F5P FRP GROUPED_DOAJ GX1 HYE KQ8 M48 O5R O5S OK1 OVT PGMZT RNS RPM TR2 W2D XSB CGR CUY CVF ECM EIF M~E NPM 7X8 5PM ACYCR |
ID | FETCH-LOGICAL-c463t-f4fc8eba04d17e4a35a600b6875b6df771c9296ca91a1cc1583ea6d6d467d8b3 |
IEDL.DBID | M48 |
ISSN | 1011-8934 |
IngestDate | Sun Mar 09 07:52:34 EDT 2025 Thu Aug 21 14:13:08 EDT 2025 Thu Jul 10 23:03:42 EDT 2025 Thu Jan 02 22:32:54 EST 2025 Thu Apr 24 23:08:47 EDT 2025 Tue Jul 01 01:44:57 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Keywords | First-line Therapy Helicobacter pylori On-line Registry Eradication Success |
Language | English |
License | http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c463t-f4fc8eba04d17e4a35a600b6875b6df771c9296ca91a1cc1583ea6d6d467d8b3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 Beom Jin Kim and Hyun-Soo Kim equally contributed to this work. G704-000345.2016.31.8.019 |
ORCID | 0000-0003-4834-0496 0000-0001-6732-9714 0000-0003-4630-4942 0000-0002-4107-9590 0000-0002-9607-6258 0000-0001-9721-5734 0000-0002-9539-9389 0000-0003-2705-778X 0000-0003-1799-9028 0000-0001-5002-9707 0000-0003-4004-6292 0000-0002-5272-1841 0000-0003-4036-2981 0000-0002-0436-3381 0000-0003-0861-2792 0000-0002-0938-6697 0000-0002-4841-9404 0000-0003-2015-5176 0000-0002-9851-5576 0000-0003-2784-3772 0000-0002-2290-4954 0000-0002-3622-9216 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3346/jkms.2016.31.8.1246 |
PMID | 27478335 |
PQID | 1808375322 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_572808 pubmedcentral_primary_oai_pubmedcentral_nih_gov_4951554 proquest_miscellaneous_1808375322 pubmed_primary_27478335 crossref_primary_10_3346_jkms_2016_31_8_1246 crossref_citationtrail_10_3346_jkms_2016_31_8_1246 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2016-08-01 |
PublicationDateYYYYMMDD | 2016-08-01 |
PublicationDate_xml | – month: 08 year: 2016 text: 2016-08-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Korea (South) |
PublicationPlace_xml | – name: Korea (South) |
PublicationTitle | Journal of Korean medical science |
PublicationTitleAlternate | J Korean Med Sci |
PublicationYear | 2016 |
Publisher | The Korean Academy of Medical Sciences 대한의학회 |
Publisher_xml | – name: The Korean Academy of Medical Sciences – name: 대한의학회 |
References | Chey (10.3346/jkms.2016.31.8.1246_ref8) 2007; 102 Kim (10.3346/jkms.2016.31.8.1246_ref4) 2013; 18 Lee (10.3346/jkms.2016.31.8.1246_ref29) 2014; 59 Kim (10.3346/jkms.2016.31.8.1246_ref23) 2006; 40 Cho (10.3346/jkms.2016.31.8.1246_ref10) 2010; 55 Park (10.3346/jkms.2016.31.8.1246_ref16) 2014; 32 Lim (10.3346/jkms.2016.31.8.1246_ref6) 2013; 13 Hwang (10.3346/jkms.2016.31.8.1246_ref21) 2010; 44 Gisbert (10.3346/jkms.2016.31.8.1246_ref1) 2011; 34 Yoon (10.3346/jkms.2016.31.8.1246_ref33) 2013; 28 Kim (10.3346/jkms.2016.31.8.1246_ref22) 2011; 57 Kim (10.3346/jkms.2016.31.8.1246_ref20) 2001; 47 Kim (10.3346/jkms.2016.31.8.1246_ref7) 2009; 54 Treiber (10.3346/jkms.2016.31.8.1246_ref24) 1997; 11 Georgopoulos (10.3346/jkms.2016.31.8.1246_ref13) 2012; 2012 Lee (10.3346/jkms.2016.31.8.1246_ref31) 2015; 21 Kuepper-Nybelen (10.3346/jkms.2016.31.8.1246_ref28) 2005; 15 McColl (10.3346/jkms.2016.31.8.1246_ref3) 2010; 362 Malfertheiner (10.3346/jkms.2016.31.8.1246_ref32) 2012; 61 Liu (10.3346/jkms.2016.31.8.1246_ref19) 2011; 16 Suerbaum (10.3346/jkms.2016.31.8.1246_ref2) 2002; 347 Fock (10.3346/jkms.2016.31.8.1246_ref5) 2008; 23 Labenz (10.3346/jkms.2016.31.8.1246_ref25) 1994; 29 Papastergiou (10.3346/jkms.2016.31.8.1246_ref30) 2014; 5 Graham (10.3346/jkms.2016.31.8.1246_ref14) 2008; 5 Suzuki (10.3346/jkms.2016.31.8.1246_ref27) 2006; 24 Chung (10.3346/jkms.2016.31.8.1246_ref15) 2011; 58 Saracino (10.3346/jkms.2016.31.8.1246_ref18) 2012; 21 Kim (10.3346/jkms.2016.31.8.1246_ref9) 2004; 48 Gong (10.3346/jkms.2016.31.8.1246_ref12) 2014; 29 Kim (10.3346/jkms.2016.31.8.1246_ref17) 2011; 58 Moayyedi (10.3346/jkms.2016.31.8.1246_ref26) 1997; 32 Choi (10.3346/jkms.2016.31.8.1246_ref11) 2006; 48 22491499 - Gut. 2012 May;61(5):646-64 16940878 - J Clin Gastroenterol. 2006 Sep;40(8):683-7 20427808 - N Engl J Med. 2010 Apr 29;362(17):1597-604 23800201 - BMC Gastroenterol. 2013 Jun 24;13:104 24851029 - J Korean Med Sci. 2014 May;29(5):704-13 19934608 - Korean J Gastroenterol. 2009 Nov;54(5):269-78 21873820 - Korean J Gastroenterol. 2011 Dec;58(2):67-73 16842453 - Aliment Pharmacol Ther. 2006 Jul 15;24(2):273-80 17608775 - Am J Gastroenterol. 2007 Aug;102(8):1808-25 25574111 - World J Gastroenterol. 2015 Jan 7;21(1):351-9 7886394 - Scand J Gastroenterol. 1994 Dec;29(12):1070-5 20571304 - Korean J Gastroenterol. 2010 Jun;55(6):368-75 24599773 - Dig Dis Sci. 2014 Jun;59(6):1235-43 21519175 - Korean J Gastroenterol. 2011 Apr;57(4):221-9 21510323 - Hepatogastroenterology. 2011 Jan-Feb;58(105):246-50 9305480 - Aliment Pharmacol Ther. 1997 Aug;11(4):711-8 18446147 - Nat Clin Pract Gastroenterol Hepatol. 2008 Jun;5(6):321-31 24732195 - Dig Dis. 2014;32(3):290-4 25400982 - World J Gastrointest Pathophysiol. 2014 Nov 15;5(4):392-9 15561865 - Antimicrob Agents Chemother. 2004 Dec;48(12):4843-7 12374879 - N Engl J Med. 2002 Oct 10;347(15):1175-86 23066652 - Helicobacter. 2013 Apr;18(2):135-42 20179610 - J Clin Gastroenterol. 2010 Sep;44(8):536-43 11266421 - J Antimicrob Chemother. 2001 Apr;47(4):459-61 22017749 - Aliment Pharmacol Ther. 2011 Dec;34(11-12):1255-68 17047430 - Korean J Gastroenterol. 2006 Sep;48(3):156-61 9058291 - J Gastroenterol. 1997 Feb;32(1):24-7 22778723 - Gastroenterol Res Pract. 2012;2012:757926 23256118 - J Gastrointestin Liver Dis. 2012 Dec;21(4):363-5 16118005 - Ann Epidemiol. 2005 Sep;15(8):607-13 21923681 - Helicobacter. 2011 Oct;16(5):356-62 24118110 - J Gastroenterol Hepatol. 2013 Dec;28(12):1801-9 18318820 - J Gastroenterol Hepatol. 2008 Mar;23(3):351-65 |
References_xml | – volume: 5 start-page: 321 year: 2008 ident: 10.3346/jkms.2016.31.8.1246_ref14 publication-title: Nat Clin Pract Gastroenterol Hepatol doi: 10.1038/ncpgasthep1138 – volume: 24 start-page: 273 year: 2006 ident: 10.3346/jkms.2016.31.8.1246_ref27 publication-title: Aliment Pharmacol Ther doi: 10.1111/j.1365-2036.2006.02994.x – volume: 5 start-page: 392 year: 2014 ident: 10.3346/jkms.2016.31.8.1246_ref30 publication-title: World J Gastrointest Pathophysiol doi: 10.4291/wjgp.v5.i4.392 – volume: 48 start-page: 156 year: 2006 ident: 10.3346/jkms.2016.31.8.1246_ref11 publication-title: Korean J Gastroenterol – volume: 58 start-page: 67 year: 2011 ident: 10.3346/jkms.2016.31.8.1246_ref17 publication-title: Korean J Gastroenterol doi: 10.4166/kjg.2011.58.2.67 – volume: 58 start-page: 246 year: 2011 ident: 10.3346/jkms.2016.31.8.1246_ref15 publication-title: Hepatogastroenterology – volume: 2012 start-page: 757926 year: 2012 ident: 10.3346/jkms.2016.31.8.1246_ref13 publication-title: Gastroenterol Res Pract doi: 10.1155/2012/757926 – volume: 23 start-page: 351 year: 2008 ident: 10.3346/jkms.2016.31.8.1246_ref5 publication-title: J Gastroenterol Hepatol doi: 10.1111/j.1440-1746.2008.05314.x – volume: 102 start-page: 1808 year: 2007 ident: 10.3346/jkms.2016.31.8.1246_ref8 publication-title: Am J Gastroenterol doi: 10.1111/j.1572-0241.2007.01393.x – volume: 59 start-page: 1235 year: 2014 ident: 10.3346/jkms.2016.31.8.1246_ref29 publication-title: Dig Dis Sci doi: 10.1007/s10620-014-3093-7 – volume: 16 start-page: 356 year: 2011 ident: 10.3346/jkms.2016.31.8.1246_ref19 publication-title: Helicobacter doi: 10.1111/j.1523-5378.2011.00856.x – volume: 32 start-page: 24 year: 1997 ident: 10.3346/jkms.2016.31.8.1246_ref26 publication-title: J Gastroenterol doi: 10.1007/BF01213292 – volume: 29 start-page: 1070 year: 1994 ident: 10.3346/jkms.2016.31.8.1246_ref25 publication-title: Scand J Gastroenterol doi: 10.3109/00365529409094890 – volume: 362 start-page: 1597 year: 2010 ident: 10.3346/jkms.2016.31.8.1246_ref3 publication-title: N Engl J Med doi: 10.1056/NEJMcp1001110 – volume: 61 start-page: 646 year: 2012 ident: 10.3346/jkms.2016.31.8.1246_ref32 publication-title: Gut doi: 10.1136/gutjnl-2012-302084 – volume: 40 start-page: 683 year: 2006 ident: 10.3346/jkms.2016.31.8.1246_ref23 publication-title: J Clin Gastroenterol doi: 10.1097/00004836-200609000-00004 – volume: 47 start-page: 459 year: 2001 ident: 10.3346/jkms.2016.31.8.1246_ref20 publication-title: J Antimicrob Chemother doi: 10.1093/jac/47.4.459 – volume: 21 start-page: 363 year: 2012 ident: 10.3346/jkms.2016.31.8.1246_ref18 publication-title: J Gastrointestin Liver Dis – volume: 29 start-page: 704 year: 2014 ident: 10.3346/jkms.2016.31.8.1246_ref12 publication-title: J Korean Med Sci doi: 10.3346/jkms.2014.29.5.704 – volume: 15 start-page: 607 year: 2005 ident: 10.3346/jkms.2016.31.8.1246_ref28 publication-title: Ann Epidemiol doi: 10.1016/j.annepidem.2004.11.001 – volume: 54 start-page: 269 year: 2009 ident: 10.3346/jkms.2016.31.8.1246_ref7 publication-title: Korean J Gastroenterol doi: 10.4166/kjg.2009.54.5.269 – volume: 57 start-page: 221 year: 2011 ident: 10.3346/jkms.2016.31.8.1246_ref22 publication-title: Korean J Gastroenterol doi: 10.4166/kjg.2011.57.4.221 – volume: 34 start-page: 1255 year: 2011 ident: 10.3346/jkms.2016.31.8.1246_ref1 publication-title: Aliment Pharmacol Ther doi: 10.1111/j.1365-2036.2011.04887.x – volume: 13 start-page: 104 year: 2013 ident: 10.3346/jkms.2016.31.8.1246_ref6 publication-title: BMC Gastroenterol doi: 10.1186/1471-230X-13-104 – volume: 28 start-page: 1801 year: 2013 ident: 10.3346/jkms.2016.31.8.1246_ref33 publication-title: J Gastroenterol Hepatol doi: 10.1111/jgh.12397 – volume: 44 start-page: 536 year: 2010 ident: 10.3346/jkms.2016.31.8.1246_ref21 publication-title: J Clin Gastroenterol doi: 10.1097/MCG.0b013e3181d04592 – volume: 11 start-page: 711 year: 1997 ident: 10.3346/jkms.2016.31.8.1246_ref24 publication-title: Aliment Pharmacol Ther doi: 10.1046/j.1365-2036.1997.00210.x – volume: 48 start-page: 4843 year: 2004 ident: 10.3346/jkms.2016.31.8.1246_ref9 publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.48.12.4843-4847.2004 – volume: 21 start-page: 351 year: 2015 ident: 10.3346/jkms.2016.31.8.1246_ref31 publication-title: World J Gastroenterol doi: 10.3748/wjg.v21.i1.351 – volume: 18 start-page: 135 year: 2013 ident: 10.3346/jkms.2016.31.8.1246_ref4 publication-title: Helicobacter doi: 10.1111/hel.12018 – volume: 55 start-page: 368 year: 2010 ident: 10.3346/jkms.2016.31.8.1246_ref10 publication-title: Korean J Gastroenterol doi: 10.4166/kjg.2010.55.6.368 – volume: 32 start-page: 290 year: 2014 ident: 10.3346/jkms.2016.31.8.1246_ref16 publication-title: Dig Dis doi: 10.1159/000357861 – volume: 347 start-page: 1175 year: 2002 ident: 10.3346/jkms.2016.31.8.1246_ref2 publication-title: N Engl J Med doi: 10.1056/NEJMra020542 – reference: 18318820 - J Gastroenterol Hepatol. 2008 Mar;23(3):351-65 – reference: 24851029 - J Korean Med Sci. 2014 May;29(5):704-13 – reference: 9305480 - Aliment Pharmacol Ther. 1997 Aug;11(4):711-8 – reference: 9058291 - J Gastroenterol. 1997 Feb;32(1):24-7 – reference: 17608775 - Am J Gastroenterol. 2007 Aug;102(8):1808-25 – reference: 24599773 - Dig Dis Sci. 2014 Jun;59(6):1235-43 – reference: 15561865 - Antimicrob Agents Chemother. 2004 Dec;48(12):4843-7 – reference: 24118110 - J Gastroenterol Hepatol. 2013 Dec;28(12):1801-9 – reference: 17047430 - Korean J Gastroenterol. 2006 Sep;48(3):156-61 – reference: 23256118 - J Gastrointestin Liver Dis. 2012 Dec;21(4):363-5 – reference: 24732195 - Dig Dis. 2014;32(3):290-4 – reference: 23066652 - Helicobacter. 2013 Apr;18(2):135-42 – reference: 22778723 - Gastroenterol Res Pract. 2012;2012:757926 – reference: 21519175 - Korean J Gastroenterol. 2011 Apr;57(4):221-9 – reference: 16842453 - Aliment Pharmacol Ther. 2006 Jul 15;24(2):273-80 – reference: 25574111 - World J Gastroenterol. 2015 Jan 7;21(1):351-9 – reference: 22491499 - Gut. 2012 May;61(5):646-64 – reference: 7886394 - Scand J Gastroenterol. 1994 Dec;29(12):1070-5 – reference: 20427808 - N Engl J Med. 2010 Apr 29;362(17):1597-604 – reference: 18446147 - Nat Clin Pract Gastroenterol Hepatol. 2008 Jun;5(6):321-31 – reference: 25400982 - World J Gastrointest Pathophysiol. 2014 Nov 15;5(4):392-9 – reference: 20571304 - Korean J Gastroenterol. 2010 Jun;55(6):368-75 – reference: 19934608 - Korean J Gastroenterol. 2009 Nov;54(5):269-78 – reference: 22017749 - Aliment Pharmacol Ther. 2011 Dec;34(11-12):1255-68 – reference: 16940878 - J Clin Gastroenterol. 2006 Sep;40(8):683-7 – reference: 20179610 - J Clin Gastroenterol. 2010 Sep;44(8):536-43 – reference: 16118005 - Ann Epidemiol. 2005 Sep;15(8):607-13 – reference: 21873820 - Korean J Gastroenterol. 2011 Dec;58(2):67-73 – reference: 12374879 - N Engl J Med. 2002 Oct 10;347(15):1175-86 – reference: 11266421 - J Antimicrob Chemother. 2001 Apr;47(4):459-61 – reference: 21510323 - Hepatogastroenterology. 2011 Jan-Feb;58(105):246-50 – reference: 21923681 - Helicobacter. 2011 Oct;16(5):356-62 – reference: 23800201 - BMC Gastroenterol. 2013 Jun 24;13:104 |
SSID | ssj0025523 |
Score | 2.2224867 |
Snippet | Eradication of Helicobacter pylori using first-line therapy is becoming less effective. Subjects who had been treated for H. pylori infection were... Eradication of Helicobacter pylori using first-line therapy is becoming less effective. Subjects who had been treated for H. pylori infection were... Eradication of Helicobacter pylori using first-line therapy is becoming less effective. Subjects who had been treated for H. pylori infection were... |
SourceID | nrf pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 1246 |
SubjectTerms | Adult Age Factors Aged Anti-Bacterial Agents - therapeutic use Databases, Factual Drug Therapy, Combination Female Helicobacter Infections - drug therapy Helicobacter Infections - microbiology Helicobacter pylori - isolation & purification Humans Internet Logistic Models Male Middle Aged Original Prospective Studies Proton Pump Inhibitors - therapeutic use Registries Republic of Korea Treatment Outcome 의학일반 |
Title | Online Registry for Nationwide Database of Current Trend of Helicobacter pylori Eradication in Korea: Interim Analysis |
URI | https://www.ncbi.nlm.nih.gov/pubmed/27478335 https://www.proquest.com/docview/1808375322 https://pubmed.ncbi.nlm.nih.gov/PMC4951554 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002131406 |
Volume | 31 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Journal of Korean Medical Science, 2016, 31(8), 218, pp.1246-1253 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Na9wwEB2SFEovod_ZtF0U6LFeVpYsy4FSQpqQD9JDSSA3IVlyYjaxE2fz9e87Y3uXbklLTwZLRljP9rynkd8AfE651yGRKirGmYukFCHKCgQkFXHw2Katpb-Rj36ovRN5cJqcLsGsKmo_gTdPSjuqJ3XSXIwerh-_4Qv_lRSnoAzl5JKMt7lCATrSI4xYahmetQkj2ssn52kFpM-x6KyH_nbhQnharpriKeb55wbK3yLS7ktY7akk2-qwfwVLoXoNz4_6ZPkbuOtsRNnPcNaWdGPIT1nng31f-sC-26mlIMbqgvU2TazdIksnMBzhM-JaL2d2Raq-ZDuN9f0SHysrdlgj4dxk7Zpieclm9iZv4Xh353h7L-rLLES5VGIaFbLIdXB2LD1Pg7QisciCnEIl45Qv0pTnyKFUbjNueZ7zRItglVcev7FeO_EOVqq6CmvAbCi0zXRiE2Gly6RzbuwE5YIVft-VG0A8m1yT9xbkVAnjwqAUIUQMIWIIESO40YYQGcCX-UVXnQPHv7tvIGpmkpeGnLPpeFabSWNQH-ybhKpxaewzw9Tg20QpEluF-vbGcGwVqODieADvO4zng5J-p1_UBpAuoD_vQOMttlTleevYjSqUeNv6f4z7AV7QDXV7DD_CyrS5DZ-Q90zdEBn__uGwXTUYts_1L8wEBds |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Online+Registry+for+Nationwide+Database+of+Current+Trend+of+Helicobacter+pylori+Eradication+in+Korea%3A+Interim+Analysis&rft.jtitle=Journal+of+Korean+medical+science&rft.au=Kim%2C+Beom+Jin&rft.au=Kim%2C+Hyun-Soo&rft.au=Song%2C+Hyun+Joo&rft.au=Chung%2C+Il-Kwun&rft.date=2016-08-01&rft.eissn=1598-6357&rft.volume=31&rft.issue=8&rft.spage=1246&rft.epage=1253&rft_id=info:doi/10.3346%2Fjkms.2016.31.8.1246&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1011-8934&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1011-8934&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1011-8934&client=summon |